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Abstract
The majority of recently emerging infectious diseases in humans is due to cross-species pathogen transmissions from
animals. To establish a productive infection in new host species, viruses must overcome barriers to replication mediated by
diverse and rapidly evolving host restriction factors such as protein kinase R (PKR). Many viral antagonists of these restriction
factors are species specific. For example, the rhesus cytomegalovirus PKR antagonist, RhTRS1, inhibits PKR in some African
green monkey (AGM) cells, but does not inhibit human or rhesus macaque PKR. To model the evolutionary changes
necessary for cross-species transmission, we generated a recombinant vaccinia virus that expresses RhTRS1 in a strain that
lacks PKR inhibitors E3L and K3L (VVDEDK+RhTRS1). Serially passaging VVDEDK+RhTRS1 in minimally-permissive AGM cells
increased viral replication 10- to 100-fold. Notably, adaptation in these AGM cells also improved virus replication 1000- to
10,000-fold in human and rhesus cells. Genetic analyses including deep sequencing revealed amplification of the rhtrs1
locus in the adapted viruses. Supplying additional rhtrs1 in trans confirmed that amplification alone was sufficient to
improve VVDEDK+RhTRS1 replication. Viruses with amplified rhtrs1 completely blocked AGM PKR, but only partially blocked
human PKR, consistent with the replication properties of these viruses in AGM and human cells. Finally, in contrast to AGM-
adapted viruses, which could be serially propagated in human cells, VVDEDK+RhTRS1 yielded no progeny virus after only
three passages in human cells. Thus, rhtrs1 amplification in a minimally permissive intermediate host was a necessary step,
enabling expansion of the virus range to previously nonpermissive hosts. These data support the hypothesis that
amplification of a weak viral antagonist may be a general evolutionary mechanism to permit replication in otherwise
resistant host species, providing a molecular foothold that could enable further adaptations necessary for efficient
replication in the new host.
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Introduction
There are at least 868 described zoonotic microbial pathogens,
33% of which are capable of human to human transmission [1].
Recent viral zoonoses have led to some of the most devastating
and medically relevant outbreaks in modern history, including
SARS coronavirus, pandemic influenza, and HIV/AIDS, high-
lighting the urgent need to understand how viruses adapt to infect
new species. At a population level, factors influencing the
transmission of zoonotic pathogens to humans include increasing
population density, greater contact with wildlife, increased travel,
and poor public health infrastructure [2,3]. However, these factors
only allow the microbe increased access to new hosts; they do not
directly enable it to adapt to and replicate in the new species.
Intermediate hosts, animals that are not the natural host of a virus
but are still permissive or semi-permissive for viral replication, play
a critical role in cross-species transmission. These hosts can
facilitate increased contact between a virus and a new host, and
drive adaptive changes that may improve virus replication
(Reviewed in [4]). For example, spill-over of Nipah virus from
fruit bats into pigs, the intermediate host, increased human
exposure to the virus and resulted in eventual human outbreaks in
Malaysia [5,6]. In another example, lentiviral adaptation through
intermediate chimpanzee hosts led to both increased contact with
humans, and adaptive genetic changes permitting the virus to
inhibit the human versions of several host restriction factors
(Reviewed in [7]).
At a molecular level, the initial success of a virus after entry into
a new host cell depends on its ability to overcome cellular host
restriction factors. A subset of these proteins inhibits specific virus
families, such as the restriction of retroviruses mediated by
TRIM5a [8]. However, other restriction factors, including protein
kinase R (PKR), block the replication of multiple virus families.
PKR is activated by binding to double-stranded RNA (dsRNA), a
common byproduct of both RNA and DNA virus replication,
followed by dimerization and autophosphorylation. Activated
PKR then phosphorylates the a-subunit of eukaryotic initiation
factor 2 (eIF2a), ultimately arresting translation initiation [9]. In
response to the broad and potent barrier to viral infection imposed
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by PKR, most virus families have evolved at least one mechanism
to inhibit the PKR pathway [10].
This conflict between host restriction factors and their viral
antagonists results in an ‘‘arms race’’ leading to rapid evolution of
both sets of genes [11]. The extraordinarily high rate of positive
selection (dN/dS) among primate PKR genes reflects the
evolutionary pressure on PKR to evade virus antagonists
[12,13]. To productively infect new host species, virus antagonists
must rapidly adapt to escape these differences in PKR. In the
current study, we modeled the process of viral adaptation through
an intermediate, minimally permissive host. We experimentally
evolved a recombinant vaccinia virus expressing the rhesus
cytomegalovirus PKR antagonist rhtrs1 in African green monkey
cells expressing RhTRS1-resistant PKR. We demonstrate that
amplification of the exogenous rhtrs1 locus was an early adaption
that is sufficient to rescue virus replication in minimally-permissive
AGM cells. This amplification of the rhtrs1 locus was also sufficient
to expand the species tropism of these viruses, enabling them to
infect both human and rhesus cells substantially better than the
initial virus. Importantly, rhtrs1 amplification did not occur when
the initial virus was passaged through human fibroblasts,
suggesting that amplification in AGM cells was a necessary
intermediate step to expand the virus host range. Gene
amplification is a universal mechanism of rapid adaptation
occurring in eukaryotes [14,15], prokaryotes [16], and viruses
[17,18], enabling diverse adaptations including evasion of host
restriction factors (Reviewed in [19]). Our results suggest that gene
amplification in an intermediate host may be a risk factor for
broad cross-species transmission independent of other adaptive
events.
Results
Variable inhibition of African green monkey PKR by
RhCMV TRS1
The rhesus cytomegalovirus (RhCMV) PKR inhibitor TRS1
(RhTRS1) can block PKR activation and rescue replication of a
vaccinia virus mutant lacking the PKR inhibitor E3L
(VVDE3L+RhTRS1) in several African green monkey (Chlorocebus
aethiops, AGM) cell lines [20]. However, we discovered that a
recombinant vaccinia virus expressing RhTRS1 and lacking both
of the known vaccinia PKR antagonists, E3L and K3L,
(VVDEDK+RhTRS1) produced 100 to 1000-fold less virus in
AGM-derived PRO1190 cells relative to VV-bg (which contains
both E3L and K3L) although it replicated almost as efficiently as
VV-bg in AGM-derived BSC40 cells (Fig. 1A). Thus, RhTRS1
varies in its ability to support VVDEDK replication in different
AGM cells.
Author Summary
The spread of microbes from animals to humans has been
responsible for most recently emerging human infectious
diseases, including AIDS, bird flu, and SARS. Therefore,
understanding the evolutionary and molecular mecha-
nisms underlying cross-species transmission is of critical
importance for public health. After entering a new host
cell, the success of a virus depends on its ability to
overcome antiviral factors in the cell, such as protein
kinase R (PKR). To investigate the process of virus
transmission between species, we employed a recombi-
nant vaccinia virus (VVDEDK+RhTRS1) expressing the
rhesus cytomegalovirus PKR antagonist RhTRS1. This
protein inhibits some African green monkey (AGM) PKRs;
however, it does not inhibit human or rhesus variants of
PKR. Serial passaging VVDEDK+RhTRS1 in RhTRS1-resistant
AGM cells resulted in rhtrs1 duplication in the viral
genome, which improved VVDEDK+RhTRS1 replication in
AGM cells. Remarkably, rhtrs1 duplication also enhanced
virus replication in human and rhesus cells. In contrast,
passage of VVDEDK+RhTRS1 in human cells, without prior
adaptation in AGM cells, did not improve VVDEDK+RhTRS1
replication. These results support the hypothesis that
amplification of a weak viral antagonist of a host defense
protein in one species may enable cross-species transmis-
sion into new hosts that are nonpermissive to the initial
virus.
Figure 1. PKR inhibits VVDEDK+RhTRS1 replication in PRO1190 cells. (A) Titers of the indicated viruses produced 48 hpi (MOI = 0.1) of
PRO1190 (gray bars) or BSC40 cells (black bars), measured using HFF+TRS1. (B) Immunoblot of lysates of PRO1190 stably transduced with lentiviral
vectors expressing control (left) or PKR-specific (right) shRNAs, probed with anti-PKR or anti-actin antibodies. (C) Titers of the indicated viruses 48 hpi
(MOI = 0.1) in either PRO1190+ctrl shRNA (grey bars) or PRO1190+PKR shRNA (black bars), measured using BSC40 cells. Results are represented as
means +1 STD.
doi:10.1371/journal.ppat.1004002.g001
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This VVDEDK+RhTRS1 replication defect in PRO1190 cells
may be due to incomplete inhibition of PKR in these cells by
RhTRS1. To test this hypothesis, we generated PRO1190 cells
stably expressing either a PKR-specific shRNA (PRO1190-PKR
kd), which resulted in a 56% reduction of PKR expression, or a
scrambled control shRNA (PRO1190-ctrl kd) (Fig. 1B). Similarly,
PKR-specific RT-qPCR demonstrated a 60% reduction in PKR
mRNA from PRO1190-PKR kd cells relative to PRO1190-ctrl kd
cells (2578 copies or 6503 copies PKR/ng total RNA respectively)
but little difference between PRO1190 and PRO1190-ctrl kd cell
PKR levels (Fig. S1). In PRO1190-PKR kd cells,
VVDEDK+RhTRS1 replication was almost completely rescued
to VV-bg levels (Fig. 1C). We detected a similar increase in
VVDEDK+RhTRS1 replication after transiently transfecting
PRO1190 cells with a siRNA specific for PKR, but not a control
siRNA (data not shown). Sequence analysis of PRO1190 PKR
identified three non-synonymous mutations relative to a previously
reported AGM PKR (GenBank # EU733254) that is sensitive to
RhTRS1 (Fig. S2, [20]). Interestingly, one of these single
nucleotide variants is heterozygous in PRO1190 cells, and changes
a residue (T577M) that is evolving under positive selection in
primates [12]. Although additional studies will be needed to
determine whether one or more of these PRO1190 PKR
polymorphisms is responsible for increased resistance to RhTRS1,
the results shown in Fig. 1 demonstrate that the block to
VVDEDK+RhTRS1 replication in PRO1190 cells is mediated
by PKR.
Rhtrs1 amplification expands virus tropism to human and
rhesus macaque cells
To determine whether VVDEDK+RhTRS1 could adapt to
overcome the PKR-mediated block to replication in PRO1190 cells,
we utilized a system of experimental evolution. We infected
PRO1190 cells with VVDEDK+RhTRS1 at a low multiplicity of
infection (MOI=0.1). 48 hours post infection (hpi) we lysed the
infected cells, titered the resulting virus, and infected new PRO1190
cells, repeating this cycle multiple times. After four passages we
observed a 10- to 100-fold increase in viral replication that
remained stable for at least three subsequent passages in each of
three independent lineages (Fig. 2). We next performed a
competition assay to assess the relative fitness of the passaged virus
in comparison to the initial VVDEDK+RhTRS1 virus. We co-
infected PRO1190 cells with either VVDEDK+RhTRS1 or VV-A,
both of which express eGFP, and the same competitor, VVDE3L
+RhTRS1, which expresses b-gal (MOI=0.1 for each virus). Virus
produced 48 hpi was titered on permissive BSC40 cells and the
specific progeny viruses were enumerated by detecting b-gal
(VVDE3L+RhTRS1) and eGFP (VVDEDK+RhTRS1 and VV-A)
expression in the plaques (Fig. S3). VVDEDK+RhTRS1 replicated
,3-fold better than VVDE3L+RhTRS1, whereas VV-A replicated
290-fold better than VVDE3L+RhTRS1, confirming that serial
passage through PRO1190 cells increased the fitness of passaged
viruses approximately 100-fold relative to the initial VVDEDK
+RhTRS1.
Since the passaged viruses replicated more efficiently in a
minimally permissive cell line, we investigated the ability of the
passaged viruses to replicate in primary cells from more divergent
primates. We have shown that RhTRS1 does not inhibit human
or rhesus PKR in the context of VVDE3L [20]. To determine
whether the adaptations that evolved during serial passage in
PRO1190 cells affected the virus species tropism, we infected
primary human foreskin fibroblasts (HFF) or primary rhesus
fibroblasts (RF) with VVDEDK+RhTRS1, each of the three
passaged virus pools or VV-bg at an MOI of 0.1 (Fig. 3). As
expected, VVDEDK+RhTRS1 replicated poorly and VV-bg
replicated efficiently in each cell type. Remarkably, all three
passaged pools replicated between 1000- to 10,000-fold better than
VVDEDK+RhTRS1 in both HFF (Fig. 3, center) and RF (Fig. 3,
right). For each pfu of VV-A, VV-B and VV-C used to infect the
cells, 5.2, 1.9, and 6.3 pfu of progeny emerged from HFF and
40.8, 7.3, and 3.7 emerged from RF, respectively, suggesting that
these viruses were sufficiently well adapted to enable continuous
propagation in these cells (see below). However, these virus pools
still replicated 10- to 100-fold better in PRO1190 than in either
human or rhesus cells (Fig. 3, left). Thus, adaptation of
VVDEDK+RhTRS1 in minimally permissive AGM fibroblasts
also provides a substantial replication benefit in human and rhesus
cells expressing distantly related PKR proteins. To elucidate the
underlying mechanism for this gain of fitness, we harvested DNA
from passage 7 viruses for genetic analyses and then passaged the
viruses once more in PRO1190 to generate viral stocks for
biochemical and infectivity analyses.
Gene amplification as a mechanism of rapid adaptation in
vaccinia virus has been well documented [17,18,21]. To determine
whether gene amplification could account for the broadly
improved replication of passaged VVDEDK+RhTRS1 we per-
formed paired-end Illumina based deep sequencing (Short Read
Archive #SRP033208). Based on read depth, we detected
duplication of the rhtrs1 locus in all three passage 7 virus pools
but not in VVDEDK+RhTRS1 (Fig. 4A). Each of the passaged
pools contained between 1.4 and 1.9 copies of rhtrs1 per genome,
although these numbers reflect averages of a heterogeneous
population of viral genomes. Confirming this estimate of rhtrs1
copy number, the frequency of reads in which we detected a
recombination site near the rhtrs1 locus increased as a percentage
of total reads in viruses predicted to have more copies of rhtrs1
(Fig. 4B).
We used PCR to confirm that the rhtrs1 locus was amplified,
using externally directed primers specific to rhtrs1 that only amplify
a product if there is a tandem duplication of the gene (Fig. S4A).
We detected 3 kb products in all three virus pools, and 2.3 kb and
1.8 kb products only in the VV-A virus pool (Fig. S4B). We were
unable to obtain enough of the 2.3 kb band for further analysis,
but we did characterize the 3 kb and 1.8 kb products by Sanger
sequencing. The larger product was identical in all three passaged
virus pools, and represents a recombination between the vaccinia
virus gene L5R upstream of rhtrs1 with J2R downstream of rhtrs1.
Figure 2. Experimental evolution of VVDEDK+RhTRS1 increases
replication fitness in PRO1190 cells. PRO1190 cells were initially
infected with VVDEDK+RhTRS1 (MOI = 0.1). Virus was harvested at
48 hpi, titered on BSC40 cells, and used to infect fresh PRO1190 cells
and the process was repeated. Three independent infections resulted in
an ,10-fold to 100-fold gain of replication fitness in PRO1190 that was
evident by passage four.
doi:10.1371/journal.ppat.1004002.g002
Gene Amplification Expands Viral Host Range
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In the smaller product J2R recombined with the neoR gene, which
was introduced as a selection marker during construction of
VVDEDK+RhTRS1 (Fig. S3C). These two sites represented the
predominant recombination sites (85.5% and 2.8% respectively)
identified by Illumina deep sequencing. However, we found
additional minor recombination sites by Illumina deep sequencing,
including a 15 kb duplication in VV-B. The presence of an
identical recombination site in all three passaged virus pools
suggests that duplication may have been present at a very low
frequency in the initial virus population even though we did not
detect it in the Illumina sequencing data. Regardless, taken
together these data demonstrate that the copy number of rhtrs1 in
the viral genome was substantially increased by passage through
PRO1190 cells.
Unlike a previous study which identified adaptive point
mutations arising after locus expansion [17], we did not detect
any point or indel mutations in rhtrs1 in any of the passaged virus
pools. However, we identified 13 vaccinia virus gene mutations
present at greater than 5% frequency in at least one of the pools
(Table 1). All three passaged pools had one or more of four
different single nucleotide deletions within the A35R gene at
frequencies ranging from 12 to 42%. Transition mutations
affecting the A24R and A37R genes were present at .50%
frequencies in VV-A and VV-B respectively, but were rare or
absent in the other viral pools. None of the other mutations were
detected in all three pools or occurred at .50% frequency in any
pool, so are unlikely to account for the improved replication of the
passaged viruses. However, the presence of these VV gene
mutations raised the question of whether the expanded species
tropism we observed was due to the VV gene mutations or to rhtrs1
amplification.
If rhtrs1 amplification alone is sufficient for the observed increase
in fitness, we reasoned that overexpression of rhtrs1 in trans might
rescue VVDEDK+RhTRS1 replication. To investigate this possi-
bility, we stably transduced rhtrs1 into HFF (HFF+RhTRS1), and
confirmed RhTRS1 expression by immunoblot (data not shown).
We also prepared a control cell line (HFF-LHCX) by transducing
the empty vector, LHCX, into HFF. In the control cells,
VVDEDK+RhTRS1 replicated approximately 1000-fold less effi-
ciently than VV-bg (Fig. 5A). In HFF+RhTRS1, VVDEDK+
RhTRS1 replication increased more than 100-fold. Thus, com-
bined expression of RhTRS1 from genes in both the cell and
the infecting virus potentiated VVDEDK+RhTRS1 replication,
Figure 3. Adaptation in minimally-permissive PRO1190 cells expands the species tropism of VVDEDK+RhTRS1. PRO1190 (left), HFF
(center), or RF (right) were infected with the indicated viruses (MOI = 0.1). Lysates were harvested 48 hpi and titered on BSC40 cells. Data are
represented as means +1 STD.
doi:10.1371/journal.ppat.1004002.g003
Figure 4. Rhtrs1 copy number variation relative to VVDEDK+
RhTRS1. (A) Relative read depth of Illumina sequencing reads in the
passaged virus pools normalized to VVDEDK+RhTRS1. The graph is
centered on the rhtrs1 locus (grey bar). (B) Copy number of RhTRS1
(rescaled so that parental strain = 1) plotted against breakpoint read
frequency (per million mapped reads) demonstrates agreement
between each independent measure of RhTRS1 duplication.
doi:10.1371/journal.ppat.1004002.g004
Gene Amplification Expands Viral Host Range
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supporting the hypothesis that rhtrs1 amplification alone is sufficient
to expand the species tropism of VVDEDK+RhTRS1.
Although rhtrs1 amplification provided a substantial growth
benefit in HFF and RF, the passaged viruses still replicated 100- to
1000-fold less efficiently than VV-bg (Fig. 3). To determine
whether this incomplete rescue in HFF was due to incomplete
PKR inhibition or represented a second block to replication, we
infected HFF stably transduced with either a PKR specific shRNA
(HFF-PKR kd) that reduces PKR expression .95%, or a non-
specific shRNA (HFF-ctrl kd) [22]. Knocking down PKR
increased VVDEDK+RhTRS1 replication ,1000-fold, indicating
that PKR is a major barrier to replication in these cells (Fig. 5B).
All three passaged virus pools replicated ,10-fold better in HFF-
PKR kd cells than in HFF-ctrl kd cells, suggesting that rhtrs1
amplification, which fully inhibits PRO1190 PKR, only partially
inhibits human PKR. However, these viruses all replicated ,10-
fold less well than VV-bg in the HFF-PKR kd cells. This
remaining replication defect may be due to incomplete PKR
knockdown in these cells [20], although it is also possible that an
additional host factor inhibits VVDEDK+RhTRS1 replication in
HFF.
RhTRS1 inhibits the PKR pathway after
autophosphorylation in multiple species
Unlike many known PKR inhibitors that block PKR phos-
phorylation [10,23], RhTRS1 inhibits the PKR pathway after
PKR phosphorylation but prior to eIF2a phosphorylation [20].
However, it is possible that RhTRS1 amplification inhibits PKR
through an alternative mechanism, such as dsRNA sequestration.
To determine whether rhtrs1 amplification altered the mechanism
of PKR inhibition, we infected PRO1190 with VV-bg, VVDE3L,
VVDEDK+RhTRS1, and VV-A at an MOI of 3, and collected
cell lysates 24 hpi. 35S metabolic labeling demonstrated that
VVDEDK+RhTRS1 expressed vaccinia virus proteins in
PRO1190 cells, though in much lower quantities than VV-bg,
consistent with the former virus being unable to inhibit PKR
completely (Fig. 6, top left panel). In contrast, VV-A produced
abundant vaccinia virus proteins, similar to VV-bg, confirming
that this virus efficiently inhibits the PKR pathway.
We used immunoblot analyses to determine the stage of the
PKR pathway inhibited by each virus (Fig. 6, lower panels).
RhTRS1 expression was noticeably higher in the VV-A infected
cells compared to those infected with VVDEDK+RhTRS1,
consistent with the better replication of VV-A in PRO1190 cells
(Fig. 6, lanes 4 and 5). PKR phosphorylation was elevated in all
virus infected cells except VV-bg, consistent with our previous
report [20] that even when RhTRS1 blocks the PKR pathway, it
does not block PKR autophosphorylation (Fig. 6, lanes 3–5).
Phospho-eIF2a levels in VVDEDK+RhTRS1 infected cells were
intermediate between mock and VVDE3L infected PRO1190
cells, suggesting that a single RhTRS1 gene weakly inhibits the
PKR pathway (Fig. 6, lane 4). Infection with VV-A resulted in low
levels of eIF2a phosphorylation, similar to that detected in VV-bg
infected PRO1190 cells (Fig. 6, compare lanes 2 and 5), indicating
that RhTRS1 amplification is sufficient to completely inhibit
PKR-mediated translational shutdown at a stage after PKR
phosphorylation. Together, these data suggest that PKR-mediated
pressure in PRO1190 cells selected for rapid amplification of the
rhtrs1 locus, and that this amplification was sufficient to enable the
virus to block PKR-mediated defenses in PRO1190 cells without
altering the mechanism of RhTRS1-mediated PKR inhibition.
In previous studies, RhTRS1 alone was insufficient to inhibit
human PKR [20]; however, the passaged viruses reported here
replicate substantially better in HFF than VVDEDK+RhTRS1,
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suggesting that amplification of rhtrs1 is able to inhibit PKR at least
partially in these cells. To test this hypothesis and determine
whether the mechanism of PKR inhibition was the same in HFF
as it is in PRO1190, we infected HFF (MOI= 3) and prepared cell
lysates 24 hpi. In contrast to infection of PRO1190 cells, infection
of HFF with VVDEDK+RhTRS1 resulted in nearly complete shut
off of protein synthesis by 24 hpi (Fig. 6, top right panel) and
produced only trace amounts of RhTRS1. Compared to
VVDEDK+RhTRS1, VV-A infection of HFF resulted in detect-
able, though still low overall levels of 35S labeled proteins, and
much more RhTRS1 (Fig. 6, lanes 9 and 10). PKR phosphory-
lation and eIF2a phosphorylation were elevated after infection
with both VVDEDK+RhTRS1 and VV-A compared to mock or
VV-bg controls (Fig. 6, compare lane 9 to lanes 6 and 7). These
data suggest that a single copy of rhtrs1 was insufficient to inhibit
the translational shutoff mediated by human PKR, but amplifi-
cation of this weak antagonist resulted in partial inhibition of
human PKR allowing enough protein synthesis to support a
modest level of virus replication.
RhTRS1 amplification in PRO1190 is a necessary
intermediate for VVDEDK+RhTRS1 replication in HFF
Because selection in AGM cells resulted in a broad expansion of
viral species tropism, we investigated whether passage of
VVDEDK+RhTRS1 directly in HFF would similarly select for
mutants, such as rhtrs1 amplification, that improved replication in
HFF. We therefore serially infected PRO1190 cells and HFF with
VVDEDK+RhTRS1 in parallel (Fig. 7). In PRO1190 cells, viral
fitness again increased after four passages. In contrast, virus
replication was strongly inhibited in HFF, and we were unable to
detect any viral replication after three rounds of infection in all
three pools. These data suggest that, under these experimental
conditions, adaptation in PRO1190 cells was a necessary
intermediate step for improved replication in HFF.
Finally, we evaluated whether the improved replication of the
viruses that had been passaged in PRO1190 cells was sufficient to
enable stable propagation in HFF. We therefore serially infected
HFF with VV-A, VV-B and VV-C at low multiplicity of infection
(MOI= 0.1 at each passage). We were able to propagate these
viruses in HFF for at least four passages. Moreover, replication
increased between 5- to 14-fold after only two passages, suggesting
further adaptation occurred in HFF cells (Fig. 7B). To define
mutations that may have evolved during serial passage in HFF, we
performed paired-end Illumina based deep sequencing on viral
DNA isolated after the fourth round of passage in HFF. Again, we
did not find any mutations in rhtrs1; however, we detected an
average rhtrs1 copy number of 1.7, 2.8, and 2.7 for the virus pools
derived from VV-A, VV-B and VV-C, respectively, representing
an average expansion of the rhtrs1 locus by approximately one
additional copy relative to the PRO1190-adapted viruses. In
addition, two VV gene mutations (in F7L [indel] and J6R) that
arose during PRO1190 adaptation were lost after HFF adaptation,
and two new mutations (in F7L [missense] and H4L) of uncertain
significance appeared during HFF adaptation (Table S3). Taken
together, our study suggests the hypothesis that gene amplification
acts broadly to increase replication in a variety of hosts, and may
provide a molecular foothold that allows for continued species-
specific adaptation of the virus in more resistant hosts.
Discussion
Cross-species pathogen transmissions have been responsible for
more than 60% of all emerging infectious diseases in humans
during the past 70 years [24]. Human immunodeficiency viruses,
avian influenza viruses, and the recently described Middle East
respiratory syndrome coronavirus exemplify the ongoing threat
and potential of animal viruses to spread to and among humans,
highlighting the urgent need to understand the mechanisms
underlying cross-species transmission and adaptation to new hosts.
One such mechanism, genetic locus amplification in response to
selective pressure, has been observed in both viruses and bacteria
[16–18,21]. Here we demonstrate that amplification of the
exogenous gene rhtrs1 is sufficient to block potent PKR-mediated
inhibition and improve VVDEDK+RhTRS1 replication in AGM-
derived PRO1190 cells. This adaptation also expanded the species
tropism of the virus, enabling markedly improved replication in
otherwise resistant human and rhesus monkey cells. Importantly,
VVDEDK+RhTRS1 failed to replicate in HFF to a level sufficient
to sustain transmission upon serial passage, demonstrating that
adaptation in PRO1190 was a critical intermediate step to expand
the viral species tropism. Thus, the process of adaptation in one
host may increase the likelihood of virus transmission to a variety
of divergent species.
Under PKR-mediated selective pressure, the rhtrs1 locus
amplified during serial passage of VVDEDK+RhTRS1 in
minimally permissive PRO1190 cells (Fig. 4). It is not clear
whether the initial duplication(s) occurred during preparation of
the VVDEDK+RhTRS1 stock in BSC40 cells or during the first
Figure 5. RhTRS1 overexpression or PKR knockdown permits efficient VVDEDK+RhTRS1 replication in HFF. (A) Viral production 48 hpi
of control (HFF+LHCX, grey bars) or HFF expressing RhTRS1 (HFF+RhTRS1, black bars) with the indicated viruses (MOI = 0.1), determined by titering on
HFF+TRS1. (B) Viral production 48 hpi of control (HFF-ctrl kd) or HFF with PKR knocked down by shRNA (HFF-PKR kd) with the indicated viruses
(MOI = 0.1), determined by titering on BSC40 cells. Data are represented as mean +1 STD.
doi:10.1371/journal.ppat.1004002.g005
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few passages in the PRO1190 cells. The observation of a faint
PCR product from the starting virus, VVDEDK+RhTRS1 using
outward directed rhtrs1 primers in one of three experiments (Fig.
S4), and the detection of an identical recombination break point in
all 3 independently passaged virus pools suggest the amplification
may have been present at a very low level in the starting virus.
However, amplification of the locus in VVDEDK+RhTRS1
occurred below the level of Illumina deep sequencing detection
(Fig. 4), supporting the idea that if rhtrs1 duplications are present
they are rare in the initial VVDEDK+RhTRS1 stock. Addition-
ally, we detected recombination between J2R and neoR (Fig. S4)
only in the VV-A pool, suggesting that recombination events did
arise during serial passage. Regardless of when they arose,
amplifications of the rhtrs1 locus were substantially enriched
during virus passage under selective pressure (Figs. 2 and 4). A
previous study demonstrated amplification of K3L as an adaptive
mechanism against human PKR with strikingly similar kinetics to
the current study [17]. Together, these two studies support the
hypothesis that preexisting or frequently arising de novo gene
duplications enable vaccinia virus to adapt rapidly to selective
conditions imposed by relatively resistant host restriction factors.
The ‘‘accordion hypothesis’’ of rapid evolution posits that gene
amplification provides a replication benefit to the virus and those
extra copies of a weak viral antagonist of host defenses provide
additional templates to acquire potentially adaptive mutations.
Indeed, Elde, et al. detected such an adaptive mutation in K3L
(H47R), apparently arising after amplification of the locus [17].
Therefore, we were surprised that no mutations arose in rhtrs1,
although it may be that additional rounds of replication would
reveal such mutations. We did, however, detect 13 mutations in
endogenous vaccinia virus genes that occurred at .5% frequency
(Fig. 4). While our data suggest that none of these mutations are
necessary to expand the species tropism of VVDEDK+RhTRS1
(Fig. 5), we have not ruled out the possibility that they may provide
some replication benefit. The presence of mutations in A24R,
A35R, and A37R are the most intriguing, as they were either
present at .50% frequency in one pool (A24R and A37R) or
detectable in all three pools (A35R). None of these genes has been
previously implicated as a PKR antagonist. A37R is conserved
across multiple poxvirus families (http://www.poxvirus.org), but
its function is unknown. A24R is a subunit of RNA polymerase. If
the mutation we identified acts like some other reported RNA
polymerase mutations to decrease transcription elongation
[25,26], this mutation might result in less dsRNA production
and therefore less PKR activation. A35R is a gene of unknown
biochemical function that may be involved in evasion of the
adaptive immune response [27,28]. All three passaged virus pools
contained nucleotide deletions in A35R at greater than 10%
frequency. A35R orthologs are conserved across most poxviruses
but, intriguingly, variola virus contains a truncation in its A35R
Figure 6. Effects of RhTRS1 overexpression on the PKR pathway in PRO1190 or HFF. PRO1190 (left) or HFF (right) were infected with the
indicated viruses (MOI = 3) for 24 hpi. Proteins were labeled with 35S-methionine for 1 h and cell lysates were analyzed by autoradiography (top
panel) or immunoblotting with the indicated antibodies (bottom panels).
doi:10.1371/journal.ppat.1004002.g006
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gene, demonstrating that similar truncations have evolved in the
past. Further studies are underway to evaluate the potential
contributions of these mutations to viral replication.
Consistent with previous studies of RhTRS1 in other AGM cell
types [20], PKR, but not eIF2a, was phosphorylated in PRO1190
cells infected with VV-A. Thus, the improved replication of the
passaged virus pools in PRO1190 cells was likely due to
enhancement of the basic RhTRS1-mediated inhibition of PKR,
and not due to another mechanism, such as dsRNA sequestration
or reduction in the abundance of dsRNA. VVDEDK+RhTRS1
infected PRO1190 cells had phospho-eIF2a levels lower than that
found in VVDE3L infected cells (Fig. 6, lanes 3 and 4), suggesting
that even just a single copy of rhtrs1 is able to inhibit PKR function
to a small degree, but amplification of the locus appears to be
needed to express enough RhTRS1 to inhibit eIF2a phosphor-
ylation potently and enable efficient viral replication. It is also
possible that elevated expression of RhTRS1 is necessary to block
another activity of PKR, such as autophagy or inflammasome
responses [29–31] that might aid in replication.
Adaptation of VVDEDK+RhTRS1 to PRO1190 cells provided
a substantial replication advantage in both human and rhesus
monkey fibroblasts. Although VV-A replicated to much higher
titers and expressed more RhTRS1 than VVDEDK+RhTRS1 in
HFF, 35S metabolic labeling revealed relatively low protein
synthesis rates and eIF2a phosphorylation was still elevated after
VV-A infection compared to VV-bg. A substantial proportion of
the block to VV-A replication in HFF is still mediated by PKR
despite RhTRS1 overexpression (Fig. 5B), suggesting that further
adaptation in HFF may be necessary to block the PKR pathway in
HFF completely. These results indicate that RhTRS1 overexpres-
sion blocks human PKR incompletely. Nonetheless, viruses that
had adapted by initial passage in PRO1190s replicated in HFF at
a level sufficient to enable sustained passage in HFF (Fig.7B).
Furthermore, these PRO1190-adapted viruses acquired additional
changes as a result of serial passage in HFF, although the
biological relevance of these changes is currently unclear.
Combined with the observation that serial passage of
VVDEDK+RhTRS1 in HFF failed to generate any adapted
viruses (Fig. 7A), these data suggest that adaptation of rhtrs1 in
minimally permissive PRO1190 cells was a critical intermediate
step in the generation of a virus with broadened species tropism.
Cross-species pathogen transmission is an important source of
emerging infections worldwide. Our study illustrates that gene
amplification of a weak viral antagonist of PKR can broaden the
host range of vaccinia virus. The presence of gene families in other
large DNA viruses, e.g. the cytomegalovirus US22 family, of which
rhtrs1 is a member, provides indirect evidence that episodes of
locus amplification have also occurred in other viruses. Adaptation
of a viral antagonist through non-synonymous mutations has the
potential to confer a species-specific advantage for the virus in a
specific host. In contrast, gene amplification and subsequent over-
expression of the antagonist is more likely to increase protein
activity through mass action effects in a variety of hosts. Thus,
gene amplification may be a common evolutionary strategy
employed by large DNA viruses, permitting modest replication
in otherwise resistant host species and providing a molecular
foothold that enables further adaptations necessary for more
efficient replication and spread in the new host.
Materials and Methods
Viruses and cell culture
AGM fibroblasts (PRO1190, Coriell Institute for Medical
Research) human foreskin fibroblasts (HFF), rhesus fibroblasts
(RF), BSC40 and HeLa cells, and derivative cell lines were
maintained in Dulbecco’s modified Eagle’s medium supplemented
with 10% NuSerum (BD Biosciences) as previously described [32].
At times, PRO1190 cell lines were also propagated in Minimal
Essential Medium with 20% fetal calf serum and anitbiotics to
enable more rapid growth. PRO1190 cells were transduced with a
nonsilencing control or PKR-targeting shRNA lentiviral vectors
(Open Biosystems, catalogue numbers RHS4430-98819555 and
RHS4346, respectively) and selected in puromycin (5 mg/ml) to
Figure 7. PRO1190-adapted viruses, but not VVDEDK+RhTRS1, stably replicate in HFF. (A) PRO1190 or HFF were infected with
VVDEDK+RhTRS1 (MOI = 0.1), for 48 h, after which viral progeny were collected, titered on BSC40 cells, and used to infect new cells (MOI = 0.1, or the
full volume of the harvested lysate when too little virus was obtained). Three independent infections resulted in a.10-fold gain of replication fitness
in PRO1190 over the course of the experiment, but no virus survived three rounds of passage through HFF. (B) HFF were infected with PRO1190-
adapted VV-A, VV-B, or VV-C virus pools (MOI = 0.1). Virus progeny harvested at 48 hpi was titered on BSC40 cells and used to infect new HFF and the
process was repeated. All three virus pools replicated in HFF for at least four rounds of serial passage, and acquired an additional, modest gain in
replication fitness.
doi:10.1371/journal.ppat.1004002.g007
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generate PRO1190-ctrl k/d and PRO1190-PKR k/d cells.
pEQ1364 was constructed by moving the RhTRS1 gene, with a
C-terminal biotinylation signal and 6x-His tag, as a HindIII/PmeI
fragment from pEQ1215 [20] into the HindIII/HpaI sites of
pLHCX (Clontech Laboratories, Inc). HFF-LHCX and
HFF+RhTRS1 were produced by transducing HFF with retroviral
vectors made using LHCX and pEQ1364, respectively and
selecting with hygromycin B (100 mg/ml).
Vaccinia virus (VV) Copenhagen strain (VC2) [33] and
VVDE3L [34], both obtained from Bertram Jacobs (Arizona
State University), and VV-bg (VC2-LacZ in [20] were propagated
and titered in BSC40 cells.
VC-R2 (VVDE3LDK3L) was constructed by replacing the E3L
gene in the K3L-deleted VACV vP872 strain (DK3L in VC2
background, provided by Bertram Jacobs) [35] by homologous
recombination. The 518 bp 59 arm was created by PCR
amplification of VC2 DNA with primers C15 (59-GATTAAGGG-
TACTAGCGGCACCG939)6C16 (59-TTTTAGAGAGAACTA-
ACACAACCAGC-39). The 512 bp 39 arm was created by PCR
amplification of VC2 DNA with primers C19 (59-GTGTAG-
TAAGCTAGCGAGCTCGGTACCTTCTAGTTATCAATAA-
CAGTTAGTAGTTTAG-39)6C20 (59-CCAACAAACTGTTC-
TCTTATGAATCG-39). The reading frame of EGFP including
the PEST sequence was amplified with primers C17 (59-GCT-
GGTTGTGTTAGTTCTCTCTAAAACCCGGGATCCACCG-
GTCGCC-39)6C18 (59-GGTACCGAGCTCGCTAGCTTAC-
TACACATTGATCCTAGCAGAAGC-39) using pD2EGFP-N1
(Clonetech) as the template. PCR products were gel-purified and
mixed together as template for fusion PCR using C156C20.
PfuUltra polymerase (Agilent Technologies) was used for these PCR
reactions. PCR products were cloned into the pCR2.1 TOPO
vector to generate plasmid S96. S96 was used as template for PCR
amplification of marker +59 and 39 arms using C156C20 followed
by gel-purification. BS-C-1 cells grown on 12 well plates were
infected with vP872 at MOI=2 and transfected 2 hours after
infection with 1 mg of the purified PCR product. Cell lysates were
collected after 18 hours and plated in a dilutions series on
RK13+E3L+K3L cells [36]. Green plaques were picked after
48 hours at the highest dilution possible and plaque purified an
additional three times on RK13+E3L+K3L cells. EGFP expression
in VC-R2 is under the control of the endogenous E3L promoter.
VVDEDK was propagated and titered using HFF+TRS1 cells (HF-
TRS1 in [37]).
VVDEDK+RhTRS1 was constructed by homologous recombi-
nation of plasmid pEQ1233 [20] into the thymidine kinase (TK)
locus of VVDEDK. Recombinant virus was plaque purified three
times in BSC40 under G418 selection and subsequently propa-
gated and titered on BSC40 cells.
PRO1190 PKR sequence analysis
Total RNA from PRO1190 cells was amplified using previously
reported PKR specific primers [12]. The amplification product was
gel purified and cloned using the StrataClone PCR cloning kit
(Agilent). Multiple plasmids were submitted for Sanger sequencing
using PKR specific sequencing primers (#859: 59-ATGGCTGGT-
GATCTTGCAC; #860: 59-GTGAACAACTCACTTGCTTC;
#861: 59-GAAACTAGACAAAGTTTTGGC; #862: 59-CTAA-
CATGTATGTCGTTCCT;#863: 59-AAGGCACTTAGTCTT-
TGATC; #864: 59-TCTGATATCTCAAGCAATGC). Contigs
were assembled and curated in Geneious Pro v4.8.5 (GenBank
#KF728076-7). The predicted amino acid sequence was aligned to
the predicted amino acid sequences of previously reported AGM
(GenBank# EU733254), rhesus macaque (GenBank# EU733261),
and human PKR (GenBank # NM001135651) using ClustalW2
(http://www.ch.embnet.org/software/ClustalW.html) [38].
Experimental evolution of VVDEDK+RhTRS1
For every round of infection, triplicate confluent 10 cm dishes
(Figure 2) or 6-well plates (Figure 7) of PRO1190 or HFF were
infected with VVDEDK+RhTRS1 (MOI= 0.1). Two days post-
infection, cells were collected, pelleted and resuspended in 1 mL
DMEM+10% NuSerum. After three freeze/thaw cycles, virus
titers were determined on BSC40 by plaque assays and used for
the next round of infection. If insufficient virus was produced to
infect cells at MOI= 0.1, the entire volume of virus lysate was used
in the subsequent round of infection.
Vaccinia virus DNA from passage 7 in PRO1190 (Figure 2) or
passage 4 in HFF (Figure 7 right) viruses was purified from
infected cell cytoplasmic extracts for genetic analyses described
below [39]. The passage 7 pools were further expanded (passage 8)
in PRO1190 for use in virologic assays.
Competition assay
PRO1190 cells were co-infected with 0.1 MOI of either
VVDEDK+RhTRS1 or VV-A, and 0.1 MOI of VVDE3L+
RhTRS1 as a common competitor. Two days post-infection cells
were collected, pelleted and resuspended in 1 mL DMEM+10%
NuSerum. After three freeze/thaw cycles, virus titers were
determined on BSC40 by plaque assays. VVDE3L+RhTRS1
plaques were detected with the b-gal substrate ImaGene Red
C12RG following the manufacturer’s directions (Life Technologies).
Plaques were imaged on a Typhoon Trio imager (eGFP - 488 nm
excitation, 520 BP 40 filter; ImaGene Red - 532 nm excitation, 580
BP 30 filter) at 50 mm/pixel resolution, and classified as GFP+,
ImaGene Red+, or double positive using ImageJ software (http://
rsb.info.nih.gov/ij/).
Genomic analyses
Externally directed PCR. Externally directed oligonucleo-
tides were designed that bind near the 59 or 39 end of RhTRS1
(#915: 59-TGTGGGAGGATGCATTGCAG; #916: 59-GGC-
GACTACAATCCCCATTG). High-fidelity PCR was performed
with 100 ng of purified virus DNA following the manufacturer’s
directions (Phusion, Thermo Scientific). Reactions were pulsed at
98uC630 s followed by 25 cycles of 98uC610 s, 65uC620 s,
72uC63 min. Amplification products were gel-purified and cloned
using the Strataclone PCR cloning kit (Agilent) following the
manufacturer’s suggested protocol. Recombination sites were
identified by Sanger sequencing of these products.
Library preparation and sequencing. From each viral
pool, 75 ng of viral DNA was sheared and ligated to adaptors by
transposition using the Nextera kit (Epicentre), following the
manufacturer’s direction with several modifications: transposition
was performed in 20 ul volume using 0.1 ml Nextera transposase
enzyme and ‘‘HMW’’ reaction buffer at final 1X. Transposition
was carried out for 10 minutes at 55uC, after which sheared,
adaptor-ligated templates were transferred directly to PCR
reactions for amplification. In addition, PCR incorporated a
sample-specific barcode tag on the reverse primer. Amplified
libraries were pooled and cleaned using Ampure beads (Beckman
Coulter) at a 1.8:1 ratio of beads to input. The pooled libraries
were sequenced on an Illumina HiSeq 2000 instrument (Illumina)
using 101-bp forward and reverse reads with a 9-bp index to read
the per-sample barcode.
Sequence analysis. De novo assembly guided by the
Vaccinia virus Copenhagen genome (GenBank #M35027.1) was
used to construct a reference assembly sequence for
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VVDEDK+RhTRS1 (Tables S1 and S2). Shotgun reads from the
parental virus were assembled to contigs using ABySS 1.3.4 [40];
parental virus reads were then realigned against the resulting
assembly contigs using bwa 0.6.1 [41]. Discrepancies between
reads and contigs, reflecting de novo assembly errors, were corrected
in the contigs following manual examination, and contigs were
ordered and concatenated by comparison to the Copenhagen
sequence.
Reads from each evolved viral pool were aligned to the parental
reference genome, and single-base and short-indel variants were
called using the Genome Analysis Toolkit [42]. Custom scripts
were used to determine the allele frequency (fraction reads
supporting variant allele out of all aligned reads at a given site) for
all variants found in any sample. Copy number was estimated by
counting the depth of read coverage within sliding windows of
100 bp, correcting for effects of differences in G+C composition,
and dividing by the parental strain read depth. Everted reads at
duplication breakpoints were identified using bwasw [43] and
custom scripts, as previously described [17].
Immunoblot analyses
Cells were mock infected or infected with vaccinia viruses
(MOI= 3). One day postinfection, the cells were lysed in 2%
sodium dodecyl sulfate (SDS). Equivalent amounts of the lysates
were separated on 10% SDS-polyacrylamide gels, transferred to
polyvinylidene difluoride (PVDF) membranes, and probed with
one of the following antibodies: PKR (sc-6282; Santa Cruz
Biotechnology, Inc.), phospho-PKR (T446; 1120-1; Epitomics),
eIF2a or phospho-eIF2a (Ser51) antibody (both from Cell
Signaling Technology, catalog numbers 9722 and 9721, respec-
tively), TRS1 a999 [37], or actin (A2066; Sigma). All purchased
antibodies were used according to the manufacturer’s recommen-
dations. Proteins were detected using the Western Star chemilu-
minescent detection system (Applied Biosystems) according to the
manufacturer’s recommendations. Densitometry measurements
were performed using ImageJ.
RT-qPCR
Total RNA was extracted from PRO1190, PRO1190-ctrl kd,
and PRO1190-PKR kd cells with TRIzol reagent following the
manufacturer’s protocol (Invitrogen), and 1 ng of total RNA was
assayed per reaction. The standard curve was generated from 10-
fold serial dilutions of a PRO1190 PKR containing plasmid
(described above in PRO1190 PKR sequence analysis, pEQ1334)
diluted in 200 pg/mL salmon sperm DNA. All samples were
amplified in triplicate using the GoTaq 1-step RT-qPCR kit
following the manufacturer’s protocol (Promega) using PKR
specific primers (#1063: 59-CACAGAATTGACGGAAAGAC;
#1064: 59-ATCCCAACAGCCATTGTAGT). RT-qPCR was
performed on a Rotor-Gene Q thermocycler (Qiagen) with
temperature holds at 37uC615 min and 95uC610 min followed
by 40 cycles of 95uC610 s, 60uC630 s. Raw data was analyzed
using the included Rotor-Gene Q series software using the
automatic cycle threshold (Ct) setting for assigning baseline and
threshold for Ct determination. Nonlinear regression analysis to
determine PKR copy number in the experimental samples was
performed in GraphPad Prism 6.
Metabolic labeling
PRO1190 and HFF cells were mock infected or infected with
the indicated viruses (MOI= 3). At 24 hpi, the cells were labeled
for 1 h with 100 mCi/ml L-[35S]methionine/L-[35S]cysteine
(EasyTag express protein labeling mix; PerkinElmer) in medium
lacking methionine and cysteine. The cells were then lysed in 2%
SDS. Equivalent amounts of protein from each sample were
separated on 10% SDS-polyacrylamide gels, dried, and visualized
by autoradiography.
Supporting Information
Figure S1 RT-qPCR analysis of PKR copy number in
PRO1190-derived cell lines. RT-qPCR was performed on
serial 10-fold dilutions of a PKR containing plasmid from 106 to
101 copies of PKR to generate a standard curve (top). Data are
represented as the mean +/2 the 95% confidence interval. PKR
copy number/ng total RNA was interpolated from this standard
curve for PRO1190, PRO1190-ctrl kd, and PRO1190-PKR kd
cells (bottom). Relative to PRO1190 cells, PRO1190-ctrl kd cells
expressed slightly less PKR (20% decrease), while PRO1190-PKR
kd cells had a 69% decrease in PKR expression. Similarly,
PRO1190-PKR kd cells expressed 60% less PKR than PKR-ctrl
kd cells, consistent with Fig. 1B.
(TIF)
Figure S2 Amino acid alignment of African green
monkey, human, and rhesus PKR. Predicted PKR amino
acid sequences from AGM (PRO1190T1610 and EU733254),
rhesus macaque (GenBank# EU733261), and human (GenBank
# NM001135651) were aligned using CLUSTAL W (1.83) [38].
We identified three non-synonymous amino acid differences (grey
or green highlighted residues) between the two AGM alleles. One
of these differences is at a site that is evolving under positive
selection in primates (green highlighted residue) [12]. Relative to
PRO1190 PKR, rhesus and human PKR are 90.8% and 83.2%
identical at the amino acid level, respectively.
(TIF)
Figure S3 Increased fitness of VV-A compared to
VVDEDK+RhTRS1 assessed by indirect competition
assay. PRO1190 cells were co-infected with either
VVDEDK+RhTRS1 or VV-A (MOI=0.1) and the same
competitor virus, VVDE3L+RhTRS1 (MOI= 0.1). Two days
post-infection viral progeny were collected and titered on
BSC40 cells. (A) Representative Typhoon image of virus titer
plates produced by infection with VVDE+RhTRS1 in combi-
nation with either VVDEDK+RhTRS1 (top panels) or VV-
A (bottom panels). (B) Plaques were scored for eGFP expression
(VVDEDK+RhTRS1 or VV-A), b-gal expression (VVDE3L+
RhTRS1) or both (double +) as described in Materials and
Methods. VV-A replicated ,100-fold better than VVDEDK+
RhTRS1 relative to VVDE3L+RhTRS1. Data are represented as
the mean +1 SD.
(TIF)
Figure S4 Predominant recombination sites identified
in rhtrs1 locus amplification. (A) Schematic of externally
directed PCR. Externally directed oligonucleotides (grey arrows)
were designed to bind to the ends of rhtrs1 (white). Only tandem
duplications will produce an amplification product. (B) Externally
directed PCR revealed enrichment of rhtrs1 amplification products
in the passaged virus pools. (C) Schematic of the initial rhtrs1 locus
in VVDEDK+RhTRS1 (top), and the predominant recombination
sites identified in all three passaged viruses (middle), or in VV-A
alone (bottom). Vaccinia virus genes are colored green or blue,
and exogenous sequences are colored dark red (rhtrs1) or brown
(neoR). PCR products amplified by externally directed primers
(black bars), the duplicated sequence (grey boxes), and the
recombination sites (red arrowheads), are indicated. Recombina-
tion sites occur (middle) after nt 84267 (J2R) and before nt 83200
(L5R) relative to the reference vaccinia virus. Copenhagen strain
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(Genbank #M35027.1), or (bottom) after nt 84237 (J2R) and
before nt 622 (neoR - pcDNA3.1, Invitrogen).
(TIF)
Table S1 Genomic coordinates for regions in whole
genome alignment between Vaccinia copenhagen refer-
ence (GenBank M35027.1) and parental genome
(VVDEDK+RhTRS1 genome) sequenced here, as deter-
mined by MUMmer 3.2.1 [44].
(DOCX)
Table S2 Substitution and short indel variants (,10 bp)
present in parental genome (VVDEDK+RhTRS1) as
compared to Vaccinia Copenhagen genome (excluding
any in the inverted terminal repeat regions). Predicted
effects upon protein coding genes as annotated in the
Copenhagen reference are listed, with more than one line
per variant indicating effects upon multiple overlapping gene
models.
(DOCX)
Table S3 Mutations identified in VV-A, VV-B and VV-C
after four passages through HFF relative to vaccinia
virus (strain Copenhagen).
(DOCX)
Table S4 Accession numbers.
(DOCX)
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